EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)

Ramucirumab Plus Paclitaxel as a Second-line Chemotherapy in Older Adults With Advanced Gastric Cancer (YCOG1601)

Sho Sato, Chikara Kunisaki, Yuko Tamura, Akikazu Yago, Kohei Kasahara, Tsutomu Sato, Hiroki Kondo, Takashi Kosaka, Hirotoshi Akiyama, Itaru Endo

Anticancer Research · 2023

DOI: 10.21873/anticanres.16771 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Anticancer Research, 2023. Verfasst von Sho Sato und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsAdenocarcinomaHumansAgedPaclitaxelNeoplasm Recurrence, LocalAntineoplastic Combined Chemotherapy ProtocolsRamucirumab

Stichwörter der Autor:innen

Older adultsgastric cancerpaclitaxelramucirumab

Substanzen

PaclitaxelRamucirumab

Autor:innen und Institutionen

  • Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan.
  • Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan; s0714@yokohama-cu.ac.jp.
  • Department of Gastroenterological Surgery, Yokohama City University School of Medicine, Yokohama, Japan.

Zitieren

APA

Sato, S., Kunisaki, C., Tamura, Y., Yago, A., Kasahara, K., Sato, T., Kondo, H., Kosaka, T., Akiyama, H., & Endo, I. (2023). Ramucirumab Plus Paclitaxel as a Second-line Chemotherapy in Older Adults With Advanced Gastric Cancer (YCOG1601). Anticancer Research. https://doi.org/10.21873/anticanres.16771

Vancouver

Sato S, Kunisaki C, Tamura Y, Yago A, Kasahara K, Sato T, et al. Ramucirumab Plus Paclitaxel as a Second-line Chemotherapy in Older Adults With Advanced Gastric Cancer (YCOG1601). Anticancer Research. 2023. doi:10.21873/anticanres.16771

BibTeX
@article{Sato2023,
  author = {Sato, Sho and Kunisaki, Chikara and Tamura, Yuko and Yago, Akikazu and Kasahara, Kohei and Sato, Tsutomu and Kondo, Hiroki and Kosaka, Takashi and Akiyama, Hirotoshi and Endo, Itaru},
  title = {Ramucirumab Plus Paclitaxel as a Second-line Chemotherapy in Older Adults With Advanced Gastric Cancer (YCOG1601)},
  journal = {Anticancer Research},
  year = {2023},
  doi = {10.21873/anticanres.16771}
}
Kostenlos starten →